Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
JAMA
    July 2018
  1. HERSHMAN DL, Unger JM, Greenlee H, Capodice JL, et al
    Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2018;320:167-176.
    >> Share

  2. ABBASI J
    Immunotherapy Leads to Complete Regression in Late-Stage Breast Cancer.
    JAMA. 2018;320:127.
    >> Share

    June 2018
  3. GILL J, Obley AJ, Prasad V
    Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    JAMA. 2018;319:2377-2378.
    >> Share

  4. PLEVRITIS SK, Berry DA, Mandelblatt JS
    Contributions of Screening and Treatment to Mortality From Breast Cancer-Reply.
    JAMA. 2018;319:2336.
    >> Share

  5. CHEN HH
    Contributions of Screening and Treatment to Mortality From Breast Cancer.
    JAMA. 2018;319:2335-2336.
    >> Share

    May 2018
  6. KEATING NL, Pace LE
    Breast Cancer Screening in 2018: Time for Shared Decision Making.
    JAMA. 2018;319:1814-1815.
    >> Share

    April 2018
  7. BEJNORDI BE, Litjens G, van der Laak JA
    Machine Learning Compared With Pathologist Assessment-Reply.
    JAMA. 2018;319:1726.
    >> Share

  8. VAN SMEDEN M, Van Calster B, Groenwold RHH
    Machine Learning Compared With Pathologist Assessment.
    JAMA. 2018;319:1725-1726.
    >> Share

    March 2018
  9. KATZ SJ, Jagsi R, Morrow M
    Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.
    JAMA. 2018;319:1091-1092.
    >> Share

    February 2018
  10. PEACHMAN RR
    Weighing the Risks and Benefits of Hormonal Contraception.
    JAMA. 2018 Feb 28. pii: 2673941. doi: 10.1001/jama.2018.0448.
    >> Share

  11. HENNEMAN JR
    In Shadow and Light-Images of Transformation Through Breast Cancer.
    JAMA. 2018;319:532-534.
    >> Share

    January 2018
  12. BALLMAN KV, McCall LM, Giuliano AE
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply.
    JAMA. 2018;319:306-307.
    >> Share

  13. UNO H, Hassett MJ, Wei LJ
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer.
    JAMA. 2018;319:306.
    >> Share

  14. PLEVRITIS SK, Munoz D, Kurian AW, Stout NK, et al
    Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
    JAMA. 2018;319:154-164.
    >> Share

  15. MANSON JE, Aragaki AK, Rossouw JE
    Menopausal Estrogen Therapy and Breast Cancer Mortality-Reply.
    JAMA. 2018;319:193-194.
    >> Share

  16. HICKEY M, McNamara HC, Mishra GD
    Menopausal Estrogen Therapy and Breast Cancer Mortality.
    JAMA. 2018;319:193.
    >> Share

    December 2017
  17. EHTESHAMI BEJNORDI B, Veta M, Johannes van Diest P, van Ginneken B, et al
    Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
    JAMA. 2017;318:2199-2210.
    >> Share

  18. GOLDEN JA
    Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen.
    JAMA. 2017;318:2184-2186.
    >> Share

    November 2017
  19. ENGELHARDT KE, Barnard C, Bilimoria KY
    Wrong-Site Surgery.
    JAMA. 2017;318:2033-2034.
    >> Share

  20. THOMAS R, Fysh ETH, Smith NA, Lee P, et al
    Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    JAMA. 2017;318:1903-1912.
    >> Share

    September 2017
  21. SLOMSKI A
    Low-Fat Diet Reduces Mortality After Breast Cancer.
    JAMA. 2017;318:1099.
    >> Share

  22. GIULIANO AE, Ballman KV, McCall L, Beitsch PD, et al
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA. 2017;318:918-926.
    >> Share

  23. LIVINGSTON EH, Li HC
    Breast Cancer Surgery: Less Is More.
    JAMA. 2017;318:909-911.
    >> Share

  24. MCNEIL M
    Menopausal Hormone Therapy: Understanding Long-term Risks and Benefits.
    JAMA. 2017;318:911-913.
    >> Share

    August 2017
  25. SLOMSKI A
    Olaparib Increased Survival in Metastatic Breast Cancer.
    JAMA. 2017;318:690.
    >> Share

    June 2017
  26. KUCHENBAECKER KB, Hopper JL, Barnes DR, Phillips KA, et al
    Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
    JAMA. 2017;317:2402-2416.
    >> Share

    April 2017
  27. HIMELSTEIN AL, Loprinzi CL, Shapiro CL
    Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply.
    JAMA. 2017;317:1478.
    >> Share

    February 2017
  28. SACKEIM MG
    Eradicating a Genetic Mutation.
    JAMA. 2017;317:809.
    >> Share

  29. ALLEN D
    Moving the Needle on Recovery From Breast Cancer: The Healing Role of Postmastectomy Tattoos.
    JAMA. 2017;317:672-674.
    >> Share

  30. RUGO HS, Klein P, Melin SA, Hurvitz SA, et al
    Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    JAMA. 2017;317:606-614.
    >> Share

  31. NANGIA J, Wang T, Osborne C, Niravath P, et al
    Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    JAMA. 2017;317:596-605.
    >> Share

  32. HERSHMAN DL
    Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
    JAMA. 2017;317:587-588.
    >> Share

  33. MUTH CC
    Chemotherapy and Hair Loss.
    JAMA. 2017;317:656.
    >> Share

  34. KURIAN AW, Griffith KA, Hamilton AS, Ward KC, et al
    Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
    JAMA. 2017;317:531-534.
    >> Share

    January 2017
  35. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    >> Share

  36. HIMELSTEIN AL, Foster JC, Khatcheressian JL, Roberts JD, et al
    Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
    JAMA. 2017;317:48-58.
    >> Share

    December 2016
  37. BURSTEIN HJ, Schrag D
    Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18979.
    >> Share

  38. RUGO HS, Barve A, Waller CF, Hernandez-Bronchud M, et al
    Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18305.
    >> Share

    November 2016
  39. ABBASI J
    The Nurses' Health Study Takes Fresh Aim at Breast Cancer as It Heads Into Decade Five.
    JAMA. 2016 Nov 23. doi: 10.1001/jama.2016.15976.
    >> Share

  40. FOUKAKIS T, von Minckwitz G, Bengtsson NO, Brandberg Y, et al
    Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016;316:1888-1896.
    >> Share

    October 2016
  41. SLOMSKI A
    Tumor Gene Testing May Help Guide Breast Cancer Treatment Decisions.
    JAMA. 2016;316:1637.
    >> Share

  42. VAN DEN BELT-DUSEBOUT AW, van Leeuwen FE, Burger CW
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization-Reply.
    JAMA. 2016;316:1713-1714.
    >> Share

  43. TOMAO F, Papa A, Tomao S
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization.
    JAMA. 2016;316:1713.
    >> Share

    July 2016
  44. VAN DEN BELT-DUSEBOUT AW, Spaan M, Lambalk CB, Kortman M, et al
    Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
    JAMA. 2016;316:300-12.
    >> Share

    May 2016
  45. CORLEY DA, Haas JS, Kobrin S
    Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.
    JAMA. 2016;315:2067-8.
    >> Share

  46. TAYLOR-PHILLIPS S, Wallis MG, Jenkinson D, Adekanmbi V, et al
    Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of Breast Cancer Detection: A Randomized Clinical Trial.
    JAMA. 2016;315:1956-65.
    >> Share

  47. BURNSIDE ES, Sickles EA, Duffy SW
    A Pragmatic Approach to Determine Components of Optimal Screening Mammography Practice.
    JAMA. 2016;315:1951-3.
    >> Share

    April 2016
  48. KRESSIN NR, Gunn CM, Battaglia TA
    Content, Readability, and Understandability of Dense Breast Notifications by State.
    JAMA. 2016;315:1786-8.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016